In the second part of a two-part interview, Vidya dives into the Bill & Melinda Gates Strategic Investment Fund (SIF) strategy investing in early-stage biotech companies as well as volume guarantees.Host: Hunter SimsProducer: Allison SimsMusic: "Nowhere Land" Kevin MacLeod (incompetech.com)Licensed under Creative Commons: By Attribution 3.0 License

Frontier Market Investing

E5: (Pt2) Vidya Vasu-Devan - Gates Strategic Investment Fund. How does early stage biotech affect the majority world? What is the impact of volume guarantees?

Welcome to Frontier Market Investing, where we hear from a wide variety of investors, from PE/VC funds to DFI's and family offices, and practitioners working in the majority world.The concept of starting a podcast about frontier markets investing originated organically from having great conversations with thought-leaders in this space. Frontier Markets Investing podcast is focused on learning from these thought-leaders, consolidating best-practice information, and raising the profile of this rewarding asset class.If you have concepts or companies you would like to hear from, please let me know and I'll respond as quickly as possible. Please leave comments on the show or visit frontiermarketinvesting.com.I hope you enjoy the content, and I look forward to hearing from you!-Hunter

About

Frontier Market Investing